Oct

08

2026

New insights into the mechanism of action of the anti-cancer drug Alpha1H are published today in Molecular Therapy, a Cell Press journal. The study ma...

Sep

24

2026

The Bio Report is a weekly podcast hosted by award-winning journalist, Daniel Levine. Produced by the Levine Media Group, the well-respected podcast f...

Sep

21

2026

New research findings defining BAMLET ‘s beneficial effects on metabolism have been published in Scientific Reports, a journal within the Nature Portf...

Sep

21

2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on September 23rd 2026, at 12:00. Please click on the link below to particip...

Sep

17

2026

HAMLET BioPharma is proud to announce that the clinical phase of the Phase III trial has started. Patients with non-muscle invasive bladder cancer are...

Aug

28

2026

    ...

Aug

27

2026

Med anledning av publiceringen av bokslutskommunikén bjuder Hamlet BioPharma in till en livesänd digital pressträff fredagen den 28 augusti, 2026, klo...

Aug

05

2026

Hamlet BioPharma AB (publ) meddelar idag det preliminära utfallet av nyttjandet av teckningsoptioner av serie TO5B. Baserat på hittills registrerade t...

Jul

28

2026

Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the grant and impending grant of new patents in the US ...

Jul

24

2026

Time Business News and  USA Wire both highlight Hamlet Biopharma’s EMA approval for the phase III study of neoaduvant therapy for early bladder ...